Venture Life Increases Share Capital After Employee Option Exercise

Venture Life ( (GB:VLG) ) has provided an update.

Venture Life Group has issued 75,000 new ordinary shares following the exercise of employee share options, with admission of these shares to trading on AIM expected to take effect on 23 January 2026. Following admission, the company will have 128,812,145 ordinary shares in issue, of which 3,313,893 are held in treasury, resulting in 125,498,252 voting rights, a figure shareholders can use to assess whether they must disclose changes in their ownership under regulatory transparency rules.

The most recent analyst rating on (GB:VLG) stock is a Hold with a £73.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.

Spark’s Take on GB:VLG Stock

According to Spark, TipRanks’ AI Analyst, GB:VLG is a Neutral.

Venture Life’s stock score is primarily supported by strong technical indicators and positive corporate events, such as share buybacks and insider buying, which suggest confidence in future prospects. However, the high P/E ratio and profitability challenges weigh down the score, indicating potential overvaluation and financial risks.

To see Spark’s full report on GB:VLG stock, click here.

More about Venture Life

Venture Life Group is a UK-headquartered international consumer self-care company operating in the global consumer healthcare sector. Its portfolio includes brands such as Balance Activ in women’s intimate healthcare, Earol for ENT care, Lift and Glucogel for energy and glucose management and hypoglycaemia, and the Health & Her range supporting the hormonal lifecycle, sold through pharmacies, health & beauty retailers, grocery multiples and e-commerce, both directly in key markets and via international distribution partners elsewhere.

Average Trading Volume: 214,342

Technical Sentiment Signal: Buy

Current Market Cap: £85.11M

Find detailed analytics on VLG stock on TipRanks’ Stock Analysis page.